|
Facebook
Twitter
Linkedin
|
First CyberKnife® System in Clinical Use in Czeh Republic
| Company News - Accuray Incorporated |
Major Czech Academic Center Expands Care to Offer Radiosurgery
Accuray Incorporated, a global leader in the field of radiosurgery, announced that the first CyberKnife Robotic Radiosurgery System in Czech Republic is now treating cancer patients at the University Hospital of Ostrava (UHO) Clinic of Oncology.
The renowned academic center has created a state-of-the-art oncology department with the addition of the CyberKnife System, which is housed in a new dedicated building. With this acquisition, the UHO is now able to significantly expand its therapeutic options by delivering high doses of radiation very precisely in only a few sessions. Their clinical program aims at treating mainly extracranial indications including lung, liver and prostate.
"With the addition of the CyberKnife System to our Radiation Oncology department, we are now able to use full body radiosurgery to target tumors that cannot be easily treated with traditional surgical techniques because of their location, number, size, shape or proximity to vital tissues or organs, or because of the age or health of the patient,” said David Feltl, M.D., Ph.D., MBA, Head of the Oncology Clinic at the UHO. “The intelligent robotics enables us to deliver radiation doses that conform closely to the shape of the tumor. This allows for precise targeting of a tumor, while at the same time minimizes damage to surrounding healthy tissue.”
“We are very pleased to see the benefits of whole body radiosurgery expand into Czech Republic,” said Vittorio Puppo, General Manager, Accuray EIMEA (Europe, India, Middle East and Africa). “This new installation paves the way for greater patient access to CyberKnife radiosurgery, thereby providing an additional treatment option to patients who may not have had other options until now.”
Source: Accuray Incorporated











